268 related articles for article (PubMed ID: 19687740)
21. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
22. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
23. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
Kaheinen P; Pollesello P; Levijoki J; Haikala H
J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
[TBL] [Abstract][Full Text] [Related]
24. The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock.
Memiş D; Inal MT; Sut N
J Crit Care; 2012 Jun; 27(3):318.e1-6. PubMed ID: 21855289
[TBL] [Abstract][Full Text] [Related]
25. Comparision of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae.
Usta C; Puddu PE; Papalia U; De Santis V; Vitale D; Tritapepe L; Mazzesi G; Miraldi F; Ozdem SS
J Cardiovasc Pharmacol; 2004 Nov; 44(5):622-5. PubMed ID: 15505502
[TBL] [Abstract][Full Text] [Related]
26. Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study.
Selli AL; Ghasemi M; Watters T; Burton F; Smith G; Dietrichs ES
Scand J Trauma Resusc Emerg Med; 2023 Oct; 31(1):61. PubMed ID: 37880801
[TBL] [Abstract][Full Text] [Related]
27. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Leppikangas H; Ruokonen E; Rutanen J; Kiviniemi V; Lindgren L; Kurola J
Ann Emerg Med; 2009 Dec; 54(6):811-817.e1-3. PubMed ID: 19766354
[TBL] [Abstract][Full Text] [Related]
28. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of the contractile effects of levosimendan in the mammalian heart.
Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N
J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207
[TBL] [Abstract][Full Text] [Related]
30. Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance.
Borow KM; Neumann A; Lang RM
Circulation; 1986 Mar; 73(3 Pt 2):III153-61. PubMed ID: 3943179
[TBL] [Abstract][Full Text] [Related]
31. Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium.
Takahashi R; Endoh M
Br J Pharmacol; 2005 Aug; 145(8):1143-52. PubMed ID: 15951828
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
33. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
34. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
[TBL] [Abstract][Full Text] [Related]
35. Contractile action of levosimendan and epinephrine during acidosis.
Toller W; Wölkart G; Stranz C; Metzler H; Brunner F
Eur J Pharmacol; 2005 Jan; 507(1-3):199-209. PubMed ID: 15659310
[TBL] [Abstract][Full Text] [Related]
36. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
37. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
[TBL] [Abstract][Full Text] [Related]
38. The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
Avgeropoulou C; Andreadou I; Markantonis-Kyroudis S; Demopoulou M; Missovoulos P; Androulakis A; Kallikazaros I
Eur J Heart Fail; 2005 Aug; 7(5):882-7. PubMed ID: 15921958
[TBL] [Abstract][Full Text] [Related]
39. Ischemia-reperfusion injury changes the dynamics of Ca2+-contraction coupling due to inotropic drugs in isolated hearts.
Rhodes SS; Ropella KM; Camara AK; Chen Q; Riess ML; Pagel PS; Stowe DF
J Appl Physiol (1985); 2006 Mar; 100(3):940-50. PubMed ID: 16282437
[TBL] [Abstract][Full Text] [Related]
40. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Hein M; Roehl AB; Baumert JH; Scherer K; Steendijk P; Rossaint R
Acta Anaesthesiol Scand; 2009 Aug; 53(7):941-8. PubMed ID: 19426242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
